Vertex Pharmaceuticals made headlines with a 14% share price jump, despite an overall market dip, thanks to clinical wins and ...

Demars Financial Group made headlines by boosting its Lockheed Martin holdings by a sky-high 47,002.5% in the fourth quarter.

Evergreen Capital Management boosted its Regeneron stake by 362.9%, snatching up 3,030 more shares and flexing some serious ...

Freedom Investment Management Inc. upped its Bristol-Myers Squibb stake by 51.3%, scooping up 6,040 extra shares and ending ...

Starbucks saw a 2% trim in holdings by NFJ Investment Group LLC in the fourth quarter, selling off 3,579 shares. Despite the minor sale, institutional investors still clutch nearly 72.3% of Starbucks ...

Automatic Data Processing Inc saw insider activity that might raise a few eyebrows and possibly a monocle or two. Corp. VP ...

Zacks Investment Management shaved 13.2% off its Marsh & McLennan holdings last quarter, selling 28,632 shares worth around ...

Boston Scientific delivered a jaw-dropping 157% return over five years, proving that fundamentals sometimes just wave from ...

CVS Health experienced a small shake-up as Guggenheim Capital LLC trimmed its stake by 3.6%, selling 13,185 shares in Q4.

Mariner LLC lightened its snack load by trimming 3.4% of its holdings in Mondelez International during Q4, selling over ...

Analog Devices saw a sharp 14.8% drop in short interest this March, suggesting traders are either gaining faith or simply ...

Jim Cramer dissected a packed earnings week with his usual flair, highlighting how political pressure for lower interest rates might crash into inflationary realities. He emphasized that “The Federal ...